These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. FOXO1 is a direct target of EWS-Fli1 oncogenic fusion protein in Ewing's sarcoma cells. Yang L; Hu HM; Zielinska-Kwiatkowska A; Chansky HA Biochem Biophys Res Commun; 2010 Nov; 402(1):129-34. PubMed ID: 20933505 [TBL] [Abstract][Full Text] [Related]
44. EWS-FLI1 in Ewing's sarcoma: real targets and collateral damage. Ban J; Siligan C; Kreppel M; Aryee D; Kovar H Adv Exp Med Biol; 2006; 587():41-52. PubMed ID: 17163154 [TBL] [Abstract][Full Text] [Related]
45. EWS-FLI1 confers exquisite sensitivity to NAMPT inhibition in Ewing sarcoma cells. Mutz CN; Schwentner R; Aryee DNT; Bouchard EDJ; Mejia EM; Hatch GM; Kauer MO; Katschnig AM; Ban J; Garten A; Alonso J; Banerji V; Kovar H Oncotarget; 2017 Apr; 8(15):24679-24693. PubMed ID: 28160567 [TBL] [Abstract][Full Text] [Related]
46. Inhibition of HDACs reduces Ewing sarcoma tumor growth through EWS-FLI1 protein destabilization. Pedot G; Marques JG; Ambühl PP; Wachtel M; Kasper S; Ngo QA; Niggli FK; Schäfer BW Neoplasia; 2022 May; 27():100784. PubMed ID: 35366465 [TBL] [Abstract][Full Text] [Related]
47. Blocking the road, stopping the engine or killing the driver? Advances in targeting EWS/FLI-1 fusion in Ewing sarcoma as novel therapy. Kovar H Expert Opin Ther Targets; 2014 Nov; 18(11):1315-28. PubMed ID: 25162919 [TBL] [Abstract][Full Text] [Related]
48. Ewing's sarcoma oncoprotein EWS-FLI1: the perfect target without a therapeutic agent. Uren A; Toretsky JA Future Oncol; 2005 Aug; 1(4):521-8. PubMed ID: 16556028 [TBL] [Abstract][Full Text] [Related]
49. A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing's sarcoma. Erkizan HV; Kong Y; Merchant M; Schlottmann S; Barber-Rotenberg JS; Yuan L; Abaan OD; Chou TH; Dakshanamurthy S; Brown ML; Uren A; Toretsky JA Nat Med; 2009 Jul; 15(7):750-6. PubMed ID: 19584866 [TBL] [Abstract][Full Text] [Related]
50. The sensitivity of the Ewing's sarcoma family of tumours to fenretinide-induced cell death is increased by EWS-Fli1-dependent modulation of p38(MAPK) activity. Myatt SS; Burchill SA Oncogene; 2008 Feb; 27(7):985-96. PubMed ID: 17700534 [TBL] [Abstract][Full Text] [Related]
51. Let-7a is a direct EWS-FLI-1 target implicated in Ewing's sarcoma development. De Vito C; Riggi N; Suvà ML; Janiszewska M; Horlbeck J; Baumer K; Provero P; Stamenkovic I PLoS One; 2011; 6(8):e23592. PubMed ID: 21853155 [TBL] [Abstract][Full Text] [Related]
52. PARP-1 inhibition as a targeted strategy to treat Ewing's sarcoma. Brenner JC; Feng FY; Han S; Patel S; Goyal SV; Bou-Maroun LM; Liu M; Lonigro R; Prensner JR; Tomlins SA; Chinnaiyan AM Cancer Res; 2012 Apr; 72(7):1608-13. PubMed ID: 22287547 [TBL] [Abstract][Full Text] [Related]
53. Combined analysis of gene expression and genome binding profiles identified potential therapeutic targets of ciclopirox in Ewing sarcoma. Yuan B; Ji W; Xia H; Li J Mol Med Rep; 2018 Mar; 17(3):4291-4298. PubMed ID: 29328472 [TBL] [Abstract][Full Text] [Related]
54. The evaluation of CD99 immunoreactivity and EWS/FLI1 translocation by fluorescence in situ hybridization in central PNETs and Ewing's sarcoma family of tumors. Vural C; Uluoğlu O; Akyürek N; Oğuz A; Karadeniz C Pathol Oncol Res; 2011 Sep; 17(3):619-25. PubMed ID: 21267687 [TBL] [Abstract][Full Text] [Related]
55. Oncoprotein EWS-FLI1 activity is enhanced by RNA helicase A. Toretsky JA; Erkizan V; Levenson A; Abaan OD; Parvin JD; Cripe TP; Rice AM; Lee SB; Uren A Cancer Res; 2006 Jun; 66(11):5574-81. PubMed ID: 16740692 [TBL] [Abstract][Full Text] [Related]
56. EWS/FLI1 regulates EYA3 in Ewing sarcoma via modulation of miRNA-708, resulting in increased cell survival and chemoresistance. Robin TP; Smith A; McKinsey E; Reaves L; Jedlicka P; Ford HL Mol Cancer Res; 2012 Aug; 10(8):1098-108. PubMed ID: 22723308 [TBL] [Abstract][Full Text] [Related]
57. FOXM1 is an oncogenic mediator in Ewing Sarcoma. Christensen L; Joo J; Lee S; Wai D; Triche TJ; May WA PLoS One; 2013; 8(1):e54556. PubMed ID: 23365673 [TBL] [Abstract][Full Text] [Related]
58. EWS-FLI1 suppresses NOTCH-activated p53 in Ewing's sarcoma. Ban J; Bennani-Baiti IM; Kauer M; Schaefer KL; Poremba C; Jug G; Schwentner R; Smrzka O; Muehlbacher K; Aryee DN; Kovar H Cancer Res; 2008 Sep; 68(17):7100-9. PubMed ID: 18757425 [TBL] [Abstract][Full Text] [Related]
59. Stable interference of EWS-FLI1 in an Ewing sarcoma cell line impairs IGF-1/IGF-1R signalling and reveals TOPK as a new target. Herrero-Martín D; Osuna D; Ordóñez JL; Sevillano V; Martins AS; Mackintosh C; Campos M; Madoz-Gúrpide J; Otero-Motta AP; Caballero G; Amaral AT; Wai DH; Braun Y; Eisenacher M; Schaefer KL; Poremba C; de Alava E Br J Cancer; 2009 Jul; 101(1):80-90. PubMed ID: 19491900 [TBL] [Abstract][Full Text] [Related]